Aducanumab: A Deep Dive into BIIB037 and its Impact This compound, originally known as BIIB037, is a notable attempt to address mild Alzheimer's disease. Designed by Biogen, aducanumab works by targeting amyloid https://www.targetmol.com/compound/aducanumab